India’s First ‘Intra-nasal Corona Vaccine’ which received DCGI approval was…
2022
India’s First ‘Intra-nasal Corona Vaccine’ which received DCGI approval was developed by ______.
Answer: C. Bharat Biotech International Limited — ConceptAn intranasal (nasal-drop/spray) vaccine is administered through the nose rather than by injection, so it builds mucosal immunity at the body's natural…
- A.
Pfizer-BioNTech
- B.
Chiron Behring
- C.
Bharat Biotech International Limited
- D.
Biomed Private Limited
Attempted by 77 students.
Show answer & explanation
Correct answer: C
Concept
An intranasal (nasal-drop/spray) vaccine is administered through the nose rather than by injection, so it builds mucosal immunity at the body's natural entry point for respiratory viruses. India's first such vaccine against COVID-19 is iNCOVACC (BBV154), which the drug regulator (CDSCO/DCGI) cleared for use.
Application
iNCOVACC was developed and manufactured by Bharat Biotech International Limited, the Hyderabad-based company (the same firm behind the injectable Covaxin). It received DCGI restricted-emergency-use approval and was later introduced as a heterologous booster. Hence the developer named in the blank is Bharat Biotech International Limited.
Contrast
Pfizer-BioNTech — makers of the mRNA injectable COVID-19 vaccine (Comirnaty); not a nasal vaccine and not an Indian developer of this product.
Chiron Behring — known for the rabies vaccine, unrelated to a COVID-19 nasal vaccine.
Biomed Private Limited — a vaccine maker not credited with India's first intranasal COVID-19 vaccine.